Company NewAmsterdam Pharma Company N.V. Börse Stuttgart
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.9 EUR | +0.56% | +6.55% | +80.81% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Transformative Therapies for Cardio-metabolic Diseases
100.0
%
| 102 | 100.0 % | 15 | 100.0 % | -85.13% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Italy
100.0
%
| 102 | 100.0 % | 15 | 100.0 % | -85.13% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 89,976,538 | 84,841,876 ( 94.29 %) | 0 | 94.29 % |
Company contact information
NewAmsterdam Pharma Co. NV
Gooimeer 2-35
1411 DC, Naarden
+31 35 206 2971
http://www.newamsterdampharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock
- Company NewAmsterdam Pharma Company N.V.